FDC regulation of self-reactive B cells

FDC 对自身反应 B 细胞的调节

基本信息

  • 批准号:
    10308457
  • 负责人:
  • 金额:
    $ 53.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-12-14 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

TITLE: FDC regulation of self-reactive B cells Abstract: Systemic lupus erythematosus (lupus) is a B cell disease characterized by secretion of pathogenic autoantibody specific for nuclear antigens or "DAMPS". A hallmark of the disease is spontaneous formation of germinal centers (GC) in spleen and lymph nodes and development of pathogenic long- lived memory B cells. Follicular dendritic cells (FDC) which are stromal derived and important in maintaining the architecture of B cell follicles are essential to formation and maintenance of GC as they are a major source of B cell antigen and survival factors. We propose FDC play a critical role in the regulation of tolerance of autoreactive B cells and their differentiation and secretion of pathogenic antibodies. Using a lupus-prone mouse model, we found that FDC uptake of nuclear antigens via CD21 triggers endosomal TLR promoting B cell loss of tolerance and differentiation. Thus, FDC are not only a critical source of self-antigen; but they are an important source of signals that can “drive” self-reactive B cells to differentiate into autoantibody producing cells and memory B cells. These findings suggest FDC may be a novel target for therapy in lupus patients. To test this possibility in a pre-clinical model, lupus mice will be treated over a period of 1 month with a blocking antibody to the CD21 receptor expressed by FDC. Our hypothesis will take advantage of several novel murine models such as a human-mouse CD21 chimeric lupus mouse where the FDC express murine CD21 and the B cells express human CD21. Using this novel system, we will test the efficacy of anti-mouse CD21 therapy in the elimination of retention of nuclear antigens by FDC and "turning-off" TLR signaling and cytokine secretion. Three aims are proposed: Aim 1. Test the hypothesis that the tolerance of self-reactive B cells is regulated by FDCs Aim 2. Test the hypothesis that the maintenance of self-reactive memory B cells is FDC-dependent Aim 3. Test the efficacy of blocking CD21 in lupus mouse models Summary: The successful completion of this study will not only provide valuable reagents and novel tools to push the field forward but it could lead to development of novel strategies and/or blocking therapies for systemic autoimmunity such as lupus.
标题:自身反应性B细胞的FDC调节 摘要: 系统性红斑狼疮(狼疮)是一种B细胞疾病,其特征是分泌致病性 对核抗原特异的自身抗体或“DAMPS”。该疾病的一个标志是自发形成 脾脏和淋巴结中的生发中心(GC)以及致病性长寿记忆B细胞的发育。 滤泡树突状细胞(Follicular dendritic cells,FDC)是间质来源的树突状细胞,在维持B细胞结构中起重要作用 卵泡对于GC的形成和维持是必需的,因为它们是B细胞抗原的主要来源, 生存因素。我们提出FDC在自身反应性B细胞耐受性的调节中起关键作用, 它们的分化和致病抗体的分泌。使用狼疮易感小鼠模型,我们发现, FDC通过CD 21摄取核抗原触发内体TLR,促进B细胞耐受性丧失, 分化因此,FDC不仅是自身抗原的关键来源,而且是免疫缺陷病毒的重要来源。 可以“驱动”自身反应性B细胞分化为自身抗体产生细胞和记忆B的信号 细胞这些发现表明FDC可能是狼疮患者治疗的新靶点。为了测试这种可能性, 在临床前模型中,狼疮小鼠将用针对CD 21的阻断抗体治疗1个月的时间 FDC表达的受体。我们的假设将利用几种新的小鼠模型,如: 人-小鼠CD 21嵌合狼疮小鼠,其中FDC表达鼠CD 21,B细胞表达 人CD 21。使用这个新系统,我们将测试抗小鼠CD 21疗法在消除CD 21方面的功效。 通过FDC保留核抗原和“关闭”TLR信号传导和细胞因子分泌。 提出了三个目标: 目标1.检验自身反应性B细胞的耐受性受FDC调节的假设 目标2.检验自我反应记忆B细胞的维持依赖于FDC的假设 目标3.在狼疮小鼠模型中测试阻断CD 21的功效 总结:本研究的成功完成不仅将为人类提供有价值的试剂和新的工具, 推动该领域向前发展,但它可能导致新的策略和/或阻断疗法的发展, 系统性自身免疫,如狼疮。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clonal Evolution of Autoreactive Germinal Centers.
自动发芽中心的克隆进化。
  • DOI:
    10.1016/j.cell.2017.07.026
  • 发表时间:
    2017-08-24
  • 期刊:
  • 影响因子:
    64.5
  • 作者:
    Degn SE;van der Poel CE;Firl DJ;Ayoglu B;Al Qureshah FA;Bajic G;Mesin L;Reynaud CA;Weill JC;Utz PJ;Victora GD;Carroll MC
  • 通讯作者:
    Carroll MC
Invasion of spontaneous germinal centers by naive B cells is rapid and persistent.
初始 B 细胞对自发生发中心的侵袭是快速且持久的。
  • DOI:
    10.1101/2023.05.30.542805
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    vandenBroek,T;Oleinika,K;Rahmayanti,S;Castrillon,C;vanderPoel,CE;Carroll,MC
  • 通讯作者:
    Carroll,MC
Complement C4A Regulates Autoreactive B Cells in Murine Lupus.
  • DOI:
    10.1016/j.celrep.2020.108330
  • 发表时间:
    2020-11-03
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Simoni L;Presumey J;van der Poel CE;Castrillon C;Chang SE;Utz PJ;Carroll MC
  • 通讯作者:
    Carroll MC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Craig Carroll其他文献

Michael Craig Carroll的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Craig Carroll', 18)}}的其他基金

Astrocyte-neuron communication and vulnerability to mental illness
星形胶质细胞-神经元通讯和患精神疾病的脆弱性
  • 批准号:
    10686440
  • 财政年份:
    2022
  • 资助金额:
    $ 53.1万
  • 项目类别:
Neuroimmune mechanisms of adolescent brain development and vulnerability
青少年大脑发育和脆弱性的神经免疫机制
  • 批准号:
    10686442
  • 财政年份:
    2022
  • 资助金额:
    $ 53.1万
  • 项目类别:
Contributions of human C4A overexpression to schizophrenia pathogenesis.
人类 C4A 过度表达对精神分裂症发病机制的贡献。
  • 批准号:
    10686441
  • 财政年份:
    2022
  • 资助金额:
    $ 53.1万
  • 项目类别:
Administrative Core (Core A)
行政核心(核心A)
  • 批准号:
    10686439
  • 财政年份:
    2022
  • 资助金额:
    $ 53.1万
  • 项目类别:
Evolution of autoreactive GC and epitope spreading in lupus
狼疮自身反应性GC和表位扩散的演变
  • 批准号:
    10736511
  • 财政年份:
    2018
  • 资助金额:
    $ 53.1万
  • 项目类别:
Evolution of autoreactive GC and epitope spreading in lupus
狼疮自身反应性GC和表位扩散的演变
  • 批准号:
    10399632
  • 财政年份:
    2018
  • 资助金额:
    $ 53.1万
  • 项目类别:
Type I interferon-dependent mechanisms of synapse loss in lupus
狼疮突触丢失的 I 型干扰素依赖性机制
  • 批准号:
    10433932
  • 财政年份:
    2018
  • 资助金额:
    $ 53.1万
  • 项目类别:
Type I interferon-dependent mechanisms of synapse loss in lupus
狼疮突触丢失的 I 型干扰素依赖性机制
  • 批准号:
    10196940
  • 财政年份:
    2018
  • 资助金额:
    $ 53.1万
  • 项目类别:
Project-004
项目-004
  • 批准号:
    10686445
  • 财政年份:
    2017
  • 资助金额:
    $ 53.1万
  • 项目类别:
Neural-immune mechanisms and synaptic connectivity in psychiatric illness
精神疾病中的神经免疫机制和突触连接
  • 批准号:
    9280281
  • 财政年份:
    2017
  • 资助金额:
    $ 53.1万
  • 项目类别:

相似海外基金

The role of IgD antibody-producing cells in the generation of allergen-specific IgE in type I allergy
IgD 抗体生成细胞在 I 型过敏中过敏原特异性 IgE 生成中的作用
  • 批准号:
    20K07537
  • 财政年份:
    2020
  • 资助金额:
    $ 53.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modulating immunological memory of antibody-producing cells
调节抗体产生细胞的免疫记忆
  • 批准号:
    17K19539
  • 财政年份:
    2017
  • 资助金额:
    $ 53.1万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Detection of specific antibody-producing cells with the enzyme-labeled antigen method in paraffin sections
石蜡切片中酶标抗原法检测特异性抗体产生细胞
  • 批准号:
    15K19063
  • 财政年份:
    2015
  • 资助金额:
    $ 53.1万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Application of an enzyme-labeled antigen method for visualizing specific antibody-producing cells in nasal polyp tissue
应用酶标抗原法可视化鼻息肉组织中特异性抗体产生细胞
  • 批准号:
    25870873
  • 财政年份:
    2013
  • 资助金额:
    $ 53.1万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Deciphering the antibody-independent functions of antibody-producing cells in autoimmune diseases (18)
破译自身免疫性疾病中抗体产生细胞的独立于抗体的功能 (18)
  • 批准号:
    243115857
  • 财政年份:
    2013
  • 资助金额:
    $ 53.1万
  • 项目类别:
    CRC/Transregios
Experimental study on induction of anti-virus antibody producing cells into the brain
抗病毒抗体产生细胞诱导进入脑内的实验研究
  • 批准号:
    23780306
  • 财政年份:
    2011
  • 资助金额:
    $ 53.1万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
How genes are regulated when antibody producing cells b ecome scavenger cells
当抗体产生细胞变成清道夫细胞时,基因如何受到调节
  • 批准号:
    nhmrc : 900126
  • 财政年份:
    1990
  • 资助金额:
    $ 53.1万
  • 项目类别:
    NHMRC Project Grants
Specific elimination of anti-DNA antibody-producing cells in systemic lupus erythematosus.
特异性消除系统性红斑狼疮中产生抗 DNA 抗体的细胞。
  • 批准号:
    59870026
  • 财政年份:
    1984
  • 资助金额:
    $ 53.1万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
PURIFICATION AND SEPARATION OF ANTIBODY -PRODUCING CELLS
抗体产生细胞的纯化和分离
  • 批准号:
    7243101
  • 财政年份:
    1972
  • 资助金额:
    $ 53.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了